Fig. 2From: Cytogenetics and FLT3-ITD mutation predict clinical outcomes in non transplant patients with acute myeloid leukemiaa OS in 141 AML patients who had WBC < 100,000/μL and WBC ≥ 100,000/μL. b RFS in 141 AML patients who had WBC < 100,000/μL and WBC ≥ 100,000/μL. c OS in 141 AML patients who achieved complete remission (CR) and non CRBack to article page